How big is the Wearable Heart Monitoring Devices Market?

The Wearable Heart Monitoring Devices Market size is expected to reach USD 2.98 billion in 2024 and grow at a CAGR of 23.22% to reach USD 8.48 billion by 2029. Read More

What is the current Wearable Heart Monitoring Devices Market size?

In 2024, the Wearable Heart Monitoring Devices Market size is expected to reach USD 2.98 billion. Read More

Which is the fastest growing region in Wearable Heart Monitoring Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Wearable Heart Monitoring Devices Market?

In 2024, the North America accounts for the largest market share in Wearable Heart Monitoring Devices Market. Read More

What years does this Wearable Heart Monitoring Devices Market cover, and what was the market size in 2023?

In 2023, the Wearable Heart Monitoring Devices Market size was estimated at USD 2.42 billion. The report covers the Wearable Heart Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Wearable Heart Monitoring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Wearable Heart Monitoring Devices Market Share

Q: Who are the key players in Wearable Heart Monitoring Devices Market?

Medtronic plc, Koninklijke Philips N.V. (BioTelemetry, Inc.), Boston Scientific (Preventice Solutions, Inc.), Asahi Kasei Corporation (ZOLL Medical Corporation) and Baxter are the major companies operating in the Wearable Heart Monitoring Devices Market. Read More

Statistics for the 2023 & 2024 Wearable Heart Monitoring Devices market share, created by Mordor Intelligence™ Industry Reports. Wearable Heart Monitoring Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Wearable Heart Monitoring Devices Industry

The wearable heart monitoring devices market is highly fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Medtronic plc, iRhythm Technologies, Inc., Baxter, Vital Connect, Inc., Asahi Kasei Corporation (ZOLL Medical Corporation), Koninklijke Philips N.V. (BioTelemetry, Inc.), Hemodynamics Company LLC, ACS Diagnostics, Inc., General Electric Company (GE Healthcare, Inc.), Boston Scientific (Preventice Solutions, Inc.), Qardio, Inc., Heartbit Holdings Plc.